Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 05 2021
Historique:
received: 29 04 2021
revised: 25 05 2021
accepted: 25 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 11 2021
Statut: epublish

Résumé

FGFR (fibroblast growth factor receptor) signaling controls fundamental processes in embryonic, fetal and adult human life. The magnitude, duration, and location of FGFR signaling must be strictly controlled in order to induce the correct biological response. Uncontrolled receptor signaling has been shown to lead to a variety of diseases, such as skeletal disorders and cancer. Here we review the numerous cellular mechanisms that regulate and turn off FGFR signaling, once the receptor is activated. These mechanisms include endocytosis and endocytic sorting, phosphatase activity, negative regulatory proteins and negative feedback phosphorylation events. The mechanisms act together simultaneously or sequentially, controlling the same or different steps in FGFR signaling. Although more work is needed to fully understand the regulation of FGFR signaling, it is clear that the cells in our body have evolved an extensive repertoire of mechanisms that together keep FGFR signaling tightly controlled and prevent excess FGFR signaling.

Identifiants

pubmed: 34071546
pii: cells10061342
doi: 10.3390/cells10061342
pmc: PMC8226934
pii:
doi:

Substances chimiques

Fibroblast Growth Factors 62031-54-3
Receptor Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a017459
pubmed: 23637288
Genes Dev. 2012 Jul 1;26(13):1421-6
pubmed: 22751498
Cell Signal. 2006 Nov;18(11):1958-66
pubmed: 16603339
Clin Sci (Lond). 2014 Aug;127(4):217-31
pubmed: 24780002
Vitam Horm. 2016;101:17-58
pubmed: 27125737
Neuroscience. 2011 Aug 11;188:13-22
pubmed: 21575685
Anat Rec (Hoboken). 2019 Aug;302(8):1268-1275
pubmed: 30950230
Biochem J. 2008 Jun 1;412(2):287-98
pubmed: 18321244
Trends Genet. 2004 Nov;20(11):563-9
pubmed: 15475116
J Biol Chem. 2006 Apr 28;281(17):12069-80
pubmed: 16505488
J Cell Biol. 2009 Oct 19;187(2):265-77
pubmed: 19822672
Biochem J. 2011 Jul 15;437(2):199-213
pubmed: 21711248
Dev Cell. 2008 Aug;15(2):209-19
pubmed: 18694561
Nat Rev Mol Cell Biol. 2020 Jan;21(1):25-42
pubmed: 31705132
J Biol Chem. 1994 Jun 24;269(25):17056-61
pubmed: 7516330
J Biochem. 2011 Feb;149(2):121-30
pubmed: 20940169
Exp Cell Res. 2009 Aug 1;315(13):2181-91
pubmed: 19362549
Br J Cancer. 2009 Dec 1;101(11):1891-9
pubmed: 19888221
Cell Signal. 2008 Aug;20(8):1471-7
pubmed: 18485666
J Clin Med. 2018 Dec 20;8(1):
pubmed: 30577533
Nat Rev Cancer. 2017 May;17(5):318-332
pubmed: 28303906
Brain. 2018 Sep 1;141(9):2772-2794
pubmed: 30059965
J Biol Chem. 2011 Jun 3;286(22):19597-604
pubmed: 21487019
Sci Signal. 2018 Sep 18;11(548):
pubmed: 30228226
Mol Biol Cell. 2004 May;15(5):2176-88
pubmed: 15004239
J Biol Chem. 2009 Mar 6;284(10):6227-40
pubmed: 19103595
Mol Biol Cell. 2011 Oct;22(20):3861-73
pubmed: 21865593
J Cell Biol. 2009 Dec 28;187(7):1101-16
pubmed: 20038681
Physiol Rev. 2003 Jan;83(1):163-82
pubmed: 12506129
Dev Biol. 2008 Sep 1;321(1):64-76
pubmed: 18582454
Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66
pubmed: 25772309
EMBO Mol Med. 2014 Apr;6(4):467-81
pubmed: 24503018
Oncogene. 2014 Oct 2;33(40):4823-36
pubmed: 24141780
Curr Biol. 2003 Jun 17;13(12):1009-18
pubmed: 12814546
Sci Signal. 2013 Feb 12;6(262):ra11
pubmed: 23405013
Br J Cancer. 2021 Mar;124(5):880-892
pubmed: 33268819
Genes Dev. 2012 Jul 15;26(14):1515-9
pubmed: 22802525
Sci Signal. 2014 Oct 07;7(346):ra95
pubmed: 25292214
Bone. 2008 Jun;42(6):1032-9
pubmed: 18374639
Mol Cell Biol. 2008 Oct;28(19):5899-911
pubmed: 18678649
FEBS J. 2013 Jan;280(2):346-78
pubmed: 23176256
Nature. 2015 Jan 22;517(7535):460-5
pubmed: 25517094
BMC Biol. 2012 Mar 15;10:25
pubmed: 22420864
Signal Transduct Target Ther. 2020 Sep 2;5(1):181
pubmed: 32879300
Nat Rev Mol Cell Biol. 2018 May;19(5):313-326
pubmed: 29410531
Mol Cell. 2002 Oct;10(4):709-19
pubmed: 12419216
Int J Biochem Cell Biol. 2012 May;44(5):748-58
pubmed: 22305891
J Cell Sci. 2013 Jan 15;126(Pt 2):613-24
pubmed: 23203811
J Biol Chem. 2003 Apr 18;278(16):14087-91
pubmed: 12604616
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):609-14
pubmed: 14699054
Biochemistry. 1996 Feb 20;35(7):2086-94
pubmed: 8652550
Mol Cell Proteomics. 2018 May;17(5):850-870
pubmed: 29371290
Annu Rev Biochem. 2018 Jun 20;87:871-896
pubmed: 29661000
J Biol Chem. 2008 Jan 18;283(3):1679-1691
pubmed: 17974561
Traffic. 2005 Oct;6(10):947-54
pubmed: 16138907
J Pediatr Surg. 2013 Nov;48(11):2219-25
pubmed: 24210189
Bioessays. 2005 Aug;27(8):849-57
pubmed: 16015590
J Cell Sci. 1998 Dec;111 ( Pt 23):3517-27
pubmed: 9811566
J Proteome Res. 2016 Oct 7;15(10):3841-3855
pubmed: 27615514
J Biol Chem. 2006 Dec 22;281(51):39225-35
pubmed: 17035228
Genes Dev. 2020 Nov 1;34(21-22):1410-1421
pubmed: 33872193
J Cell Sci. 2001 May;114(Pt 9):1677-89
pubmed: 11398757
Biochem Biophys Res Commun. 2005 Feb 11;327(2):523-32
pubmed: 15629145
FEBS Lett. 2003 Oct 23;553(3):262-70
pubmed: 14572635
Cancer Cell. 2002 Oct;2(4):301-14
pubmed: 12398894
PLoS One. 2012;7(1):e29739
pubmed: 22235335
Biochem Biophys Res Commun. 2006 Dec 29;351(4):1018-23
pubmed: 17094949
Dev Cell. 2010 Sep 14;19(3):426-39
pubmed: 20833364
J Biol Chem. 2007 Mar 23;282(12):9117-26
pubmed: 17255109
J Biol Chem. 2011 Jul 8;286(27):24443-50
pubmed: 21596750
J Biol Chem. 2004 Aug 27;279(35):36259-67
pubmed: 15190072
J Cell Sci. 2005 Dec 15;118(Pt 24):5861-71
pubmed: 16339969
Sci Signal. 2012 May 08;5(223):ra36
pubmed: 22569333
Mol Biol Evol. 2014 Feb;31(2):310-8
pubmed: 24222650
Mol Cell Biol. 1992 Jan;12(1):82-8
pubmed: 1309595
EMBO J. 2011 Jul 15;30(16):3259-73
pubmed: 21765395
Proteomics. 2015 Jan;15(2-3):419-33
pubmed: 25311528
Traffic. 2014 Jun;15(6):665-83
pubmed: 24589086
FEBS Lett. 2002 Sep 25;528(1-3):83-9
pubmed: 12297284
J Biol Chem. 2004 May 28;279(22):22992-5
pubmed: 15031289
Elife. 2019 Oct 02;8:
pubmed: 31577229
FEBS Lett. 2010 Nov 5;584(21):4383-8
pubmed: 20932831
Cold Spring Harb Perspect Biol. 2013 Nov 01;5(11):a009035
pubmed: 24186066
Curr Opin Cell Biol. 2003 Apr;15(2):128-35
pubmed: 12648667
Dev Biol. 2005 Nov 15;287(2):390-402
pubmed: 16216232
Cell. 1994 Jul 29;78(2):335-42
pubmed: 7913883
Nature. 2001 Aug 9;412(6847):647-51
pubmed: 11493923
Science. 1998 May 22;280(5367):1262-5
pubmed: 9596579
Curr Biol. 2009 Apr 28;19(8):706-12
pubmed: 19345102
Oncogene. 1997 Jul 31;15(5):525-36
pubmed: 9247306
Nat Cell Biol. 2011 Feb;13(2):153-8
pubmed: 21258372
J Mol Biol. 1992 Jan 20;223(2):531-43
pubmed: 1738162
Nature. 1994 Dec 15;372(6507):631-4
pubmed: 7990952
J Biol Chem. 2002 Feb 1;277(5):3195-201
pubmed: 11698404
Cells. 2019 May 29;8(6):
pubmed: 31146385
FEBS J. 2007 Jun;274(12):3078-93
pubmed: 17509076
Curr Opin Cell Biol. 2021 Apr 13;71:120-129
pubmed: 33862329
Anticancer Res. 2005 Nov-Dec;25(6B):3877-82
pubmed: 16309174
Cancer Res. 2008 Jun 15;68(12):4649-57
pubmed: 18559510
Mol Cell. 2013 Sep 26;51(6):707-22
pubmed: 24011590
J Cell Physiol. 2012 Jun;227(6):2480-91
pubmed: 21830216
J Biochem. 2004 Nov;136(5):557-61
pubmed: 15632293
Sci Rep. 2017 Aug 2;7(1):7121
pubmed: 28769084
Differentiation. 2010 Jul;80(1):53-67
pubmed: 20542628
Genes Dev. 2015 Jul 15;29(14):1463-86
pubmed: 26220993
J Biol Chem. 2000 Mar 17;275(11):7771-8
pubmed: 10713090
J Biol Chem. 2013 Jun 14;288(24):17859-70
pubmed: 23640895
Traffic. 2007 Dec;8(12):1854-72
pubmed: 17944804
J Biol Chem. 2013 May 24;288(21):14874-85
pubmed: 23564461
Biochem Biophys Res Commun. 2006 Sep 8;347(4):988-93
pubmed: 16859641
Sci Rep. 2019 Mar 5;9(1):3480
pubmed: 30837551
Exp Cell Res. 2020 Oct 15;395(2):112236
pubmed: 32798495
Mol Cell Biol. 1991 Oct;11(10):5068-78
pubmed: 1656221
Mol Biol Cell. 2005 Jan;16(1):14-23
pubmed: 15509650
Nat Cell Biol. 2002 Nov;4(11):850-8
pubmed: 12402043
Birth Defects Res C Embryo Today. 2010 Sep;90(3):214-27
pubmed: 20860061
J Cell Biol. 2012 Jun 11;197(6):801-17
pubmed: 22665522
Adv Cancer Res. 1993;60:1-41
pubmed: 8417497
Annu Rev Cell Dev Biol. 2018 Oct 6;34:85-109
pubmed: 30095293
Mol Cell Biol. 1998 Jul;18(7):3966-73
pubmed: 9632781
Development. 2007 Jan;134(1):167-76
pubmed: 17164422
Cell Mol Life Sci. 2016 Dec;73(23):4397-4413
pubmed: 27342992
Mol Biol Rep. 2020 Dec;47(12):9801-9810
pubmed: 33185829
Nat Rev Mol Cell Biol. 2018 Nov;19(11):679-696
pubmed: 30194414
Nat Cell Biol. 2003 Jun;5(6):513-9
pubmed: 12766772
Mol Biol Cell. 2008 Aug;19(8):3390-403
pubmed: 18480409
J Cell Sci. 2005 Sep 1;118(Pt 17):3869-81
pubmed: 16091423
J Biol Chem. 2005 Aug 5;280(31):28572-80
pubmed: 15946934
Mol Cancer Res. 2004 Nov;2(11):643-52
pubmed: 15561780
Curr Biol. 2004 Oct 26;14(20):1834-41
pubmed: 15498491
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6684-9
pubmed: 11997436
Cell. 2012 Jun 22;149(7):1514-24
pubmed: 22726438
Nat Cell Biol. 2002 Feb;4(2):170-4
pubmed: 11802165
Oncogene. 2015 Jan 22;34(4):474-84
pubmed: 24469046
Biol Cell. 2021 Apr;113(4):165-182
pubmed: 33617023
PLoS One. 2011;6(7):e21708
pubmed: 21779335
Genes Dev. 2016 Apr 1;30(7):751-71
pubmed: 27036966

Auteurs

Patrycja Szybowska (P)

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.
Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.

Michal Kostas (M)

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.
Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.

Jørgen Wesche (J)

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.
Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.

Ellen Margrethe Haugsten (EM)

Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.
Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.

Antoni Wiedlocha (A)

Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, 0379 Oslo, Norway.
Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, 0379 Oslo, Norway.
Military Institute of Hygiene and Epidemiology, 01-163 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH